Watchlists Portfolios Alerts Sign in Get started

Menu

Market-Moving News for November 4th

Benzinga Newsdesk Nov 4, 2025 12 months ago

MoversTrading Ideas

PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms NSP: -32% | Insperity shares are trading

PRLD: 70% | Prelude Therapeutics Signs Agreement For Incyte To Acquire JAK2V617F JH2 Inhibitor Program In Development For Patients With Myeloproliferative Neoplasms

NSP: -32% | Insperity shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY25 adjusted EPS and GAAP EPS guidance below estimates. Also, the company issued Q4 adjusted EPS and GAAP EPS guidance below estimates.

SRPT: -41% | Sarepta Therapeutics shares are trading lower after the company reported Q3 financial results. Also, the company announced that its ESSENCE study did not achieve statistical significance on its primary endpoint.

Read the original